TP53 and mantle cell lymphoma: Secondary genetic events are associated with MCL progression and transformation to blastoid subtypes, including loss of tumor suppressor genes such as ATM, CDKN2A, and TP53 and gain of the oncogenes MYC, SYK, and BCL2, justifying its biological heterogeneity [4,6,7,8].